Foundation Fighting Blindness Retinal Degeneration Fund - Insider Non-Derivative Transactions at Opus Genetics, Inc. (IRD) - (SEC)

Updated on March 12, 2026.

According to recent SEC insider information filed on Dec 9, 2025, Foundation Fighting Blindness Retinal Degeneration Fund's relationship to Opus Genetics, Inc. (IRD) is Director,Other, and currently has 5,492,171 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other IRD insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Foundation Fighting Blindness Retinal Degeneration Fund - Insider Non-Derivative Transactions of IRD Common Stock

Foundation Fighting Blindness Retinal Degeneration Fund - Insider Non-Derivative Transactions at IRD

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 10, 2025	Sell -- (Common Stock)	4000000	2.15	5492171